|
1
|
Compare D, Rocco A and Nardone G: Risk
factors in gastric cancer. Eur Rev Med Pharmacol Sci. 14:302–308.
2010.
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
3
|
Petrocca F, Visone R, Onelli MR, Shah MH,
Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini
M, et al: E2F1-regulated microRNAs impair TGFbeta-dependent
cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell.
13:272–286. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bessette DC, Qiu D and Pallen CJ: PRL
PTPs: mediators and markers of cancer progression. Cancer
Metastasis Rev. 27:231–252. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Andersen JN, Jansen PG, Echwald SM,
Mortensen OH, Fukada T, Del Vecchio R, Tonks NK and Møller NP: A
genomic perspective on protein tyrosine phosphatases: gene
structure, pseudogenes, and genetic disease linkage. Faseb J.
18:8–30. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alonso A, Sasin J, Bottini N, Friedberg I,
Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J and Mustelin
T: Protein tyrosine phosphatases in the human genome. Cell.
117:699–711. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu X, Zeng H, Zhang X, Zhao Y, Sha H, Ge
X, Zhang M, Gao X and Xu Q: Phosphatase of regenerating liver-3
promotes motility and metastasis of mouse melanoma cells. Am J
Pathol. 164:2039–2054. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stephens B, Han H, Hostetter G, Demeure MJ
and Von Hoff DD: Small interfering RNA-mediated knockdown of PRL
phosphatases results in altered Akt phosphorylation and reduced
clonogenicity of pancreatic cancer cells. Mol Cancer Ther.
7:202–210. 2008. View Article : Google Scholar
|
|
9
|
Zeng Q, Dong JM, Guo K, Li J, Tan HX, Koh
V, Pallen CJ, Manser E and Hong W: PRL-3 and PRL-1 promote cell
migration, invasion, and metastasis. Cancer Res. 63:2716–2722.
2003.PubMed/NCBI
|
|
10
|
Radke I, Götte M, Kersting C, Mattsson B,
Kiesel L and Wülfing P: Expression and prognostic impact of the
protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast
cancer. Br J Cancer. 95:347–354. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou J, Wang S, Lu J, Li J and Ding Y:
Over-expression of phosphatase of regenerating liver-3 correlates
with tumor progression and poor prognosis in nasopharyngeal
carcinoma. Int J Cancer. 124:1879–1886. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li ZR, Wang Z, Zhu BH, He YL, Peng JS, Cai
SR, Ma JP and Zhan WH: Association of tyrosine PRL-3 phosphatase
protein expression with peritoneal metastasis of gastric carcinoma
and prognosis. Surg Today. 37:646–651. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sharma GD, He J and Bazan HE: p38 and ERK
1/2 coordinate cellular migration and proliferation in epithelial
wound healing: evidence of cross-talk activation between MAP kinase
cascades. J Biol Chem. 278:21989–21997. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mu H, Wang X, Wang H, Lin P, Yao Q and
Chen C: Lactosylceramide promotes cell migration and proliferation
through activation of ERK1/2 in human aortic smooth muscle cells.
Am J Physiol Heart Circ Physiol. 297:H400–H408. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
McCawley LJ, Li S, Wattenberg EV and
Hudson LG: Sustained activation of the mitogen-activated protein
kinase pathway. A mechanism underlying receptor tyrosine kinase
specificity for matrix metalloproteinase-9 induction and cell
migration. J Biol Chem. 274:4347–4353. 1999. View Article : Google Scholar
|
|
16
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar
|
|
17
|
Björklund M and Koivunen E:
Gelatinase-mediated migration and invasion of cancer cells. Biochim
Biophys Acta. 1755:37–69. 2005.PubMed/NCBI
|
|
18
|
Luo Y, Liang F and Zhang ZY: PRL1 promotes
cell migration and invasion by increasing MMP2 and MMP9 expression
through Src and ERK1/2 pathways. Biochemistry. 48:1838–1846. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zeng Q, Si X, Horstmann H, Xu Y, Hong W
and Pallen CJ: Prenylation-dependent association of
protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma
membrane and the early endosome. J Biol Chem. 275:21444–21452.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kato H, Semba S, Miskad UA, Seo Y, Kasuga
M and Yokozaki H: High expression of PRL-3 promotes cancer cell
motility and liver metastasis in human colorectal cancer: a
predictive molecular marker of metachronous liver and lung
metastases. Clin Cancer Res. 10:7318–7328. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lawrie CH, Gal S, Dunlop HM, Pushkaran B,
Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J,
Wainscoat JS, et al: Detection of elevated levels of
tumour-associated microRNAs in serum of patients with diffuse large
B-cell lymphoma. Br J Haematol. 141:672–675. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Weiss L: Metastasis of cancer: a
conceptual history from antiquity to the 1990s. Cancer Metastasis
Rev. 19:193–383. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun P, Yu H, Zhang WQ, Hu M and Lv R:
Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer
growth in vivo. Oncol Rep. 28:1687–1692. 2012.PubMed/NCBI
|
|
25
|
Qin XJ, Dai DJ, Gao ZG, Huan JL and Zhu L:
Effect of lentivirus-mediated shRNA targeting VEGFR-3 on
proliferation, apoptosis and invasion of gastric cancer cells. Int
J Mol Med. 28:761–768. 2011.PubMed/NCBI
|
|
26
|
Dai N, Lu AP, Shou CC and Li JY:
Expression of phosphatase regenerating liver 3 is an independent
prognostic indicator for gastric cancer. World J Gastroenterol.
15:1499–1505. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Z, Cai SR, He YL, Zhan WH, Chen CQ,
Cui J, Wu WH, Wu H, Song W, Zhang CH, et al: High expression of
PRL-3 can promote growth of gastric cancer and exhibits a poor
prognostic impact on patients. Ann Surg Oncol. 16:208–219. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Miskad UA, Semba S, Kato H, Matsukawa Y,
Kodama Y, Mizuuchi E, Maeda N, Yanagihara K and Yokozaki H: High
PRL-3 expression in human gastric cancer is a marker of metastasis
and grades of malignancies: an in situ hybridization study.
Virchows Arch. 450:303–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ming J, Liu N, Jiang GC, Zhang QF, Qiu XS
and Wang EH: Downregulating PRL-3 inhibit migration and invasion of
lung cancer cell via RhoA and mDia1. Tumori. 98:370–376.
2012.PubMed/NCBI
|
|
30
|
Mizuuchi E, Semba S, Kodama Y and Yokozaki
H: Down-modulation of keratin 8 phosphorylation levels by PRL-3
contributes to colorectal carcinoma progression. Int J Cancer.
124:1802–1810. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Peng L, Jin G, Wang L, Guo J, Meng L and
Shou C: Identification of integrin alpha1 as an interacting protein
of protein tyrosine phosphatase PRL-3. Biochem Biophys Res Commun.
342:179–183. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kwak DH, Lee JH, Kim T, Ahn HS, Cho WK, Ha
H, Hwang YH and Ma JY: Aristolochia manshuriensis Kom inhibits
adipocyte differentiation by regulation of ERK 1/2 and Akt pathway.
PLoS One. 7:e495302012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma L, Lan F, Zheng Z, Xie F, Wang L, Liu
W, Han J, Zheng F, Xie Y and Huang Q: Epidermal growth factor (EGF)
and interleukin (IL)-1β synergistically promote ERK1/2-mediated
invasive breast ductal cancer cell migration and invasion. Mol
Cancer. 11:792012.
|
|
34
|
Yang Y, Shi H, Li X and Yi Y: Effects of
shRNA targeting maspin on invasion of gastric carcinoma SGC7901
cell line. Oncol Rep. 25:259–265. 2011.PubMed/NCBI
|
|
35
|
Koskensalo S, Mrena J, Wiksten JP,
Nordling S, Kokkola A, Hagström J and Haglund C: MMP-7
overexpression is an independent prognostic marker in gastric
cancer. Tumour Biol. 31:149–155. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zeng Q, Hong W and Tan YH: Mouse PRL-2 and
PRL-3, two potentially prenylated protein tyrosine phosphatases
homologous to PRL-1. Biochem Biophys Res Commun. 244:421–427. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cates CA, Michael RL, Stayrook KR, Harvey
KA, Burke YD, Randall SK, Crowell PL and Crowell DN: Prenylation of
oncogenic human PTP (CAAX) protein tyrosine phosphatases. Cancer
Lett. 110:49–55. 1996. View Article : Google Scholar : PubMed/NCBI
|
